登记Id

PA162364313

药物名称(英)

bezafibrate

通用名称

Bezafibrat,Bezafibrato [inn-spanish],Bezafibratum [inn-latin]

商品名称

"Befizal","Bezalip","Bezalip retard","Bezatol","Bezatol SR","Cedur"

品牌组合

Hepaconda (bezafibrate + chenodeoxycholic acid)

类型(英)

Drug

类型

药品

交叉引用

"BindingDB:28701","Canadian Drugs Product Database:02083523","ChEBI:CHEBI:31284","ChEBI:CHEBI:47612","Chemical Abstracts Service:41859-67-0","ChemSpider:35728","DrugBank:DB01393","HET:PEM","KEGG Drug:D01366","PDB:PEM","PubChem Compound:39042","PubChem Substance:10321679","PubChem Substance:46509188","Therapeutic Targets Database:DAP001182","URL:http://en.wikipedia.org/wiki/Bezafibrate"

简化分子线性输入规范

CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl

键

InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)

剂量指南

No

外部词汇

"ATC:C10AB02(bezafibrate)","UMLS:C0005330(Bezafibrate)","RxNorm:1525(Bezafibrate)","NDFRT:N0000166742(Bezafibrate [Chemi

RxNorm 标识符

1525

ATC 标识符

C10AB02

化合物标识符

39042